Altmetric Blog

Archive: January 2017

Though altmetrics’ ability to directly predict “real world” impact is still very much under debate, one research team has found that the presence of altmetrics is related to the broader impacts of their REF2014-submitted research. We spoke to Dr. Jenny Wooldridge, a member of the National Physical Laboratory (NPL) Impact Evaluation team, to learn more about her team’s research that uses expert peer review, citations, and altmetrics to understand the attention and related impacts that UK research has received. Exploring the data Initially, Jenny’s team used the Altmetric Explorer for Institutions platform to run reports … Read More
The following was originally posted by Altmetric’s Founder, Euan Adie, on LinkedIn Pulse on the 29th November 2016: Hello! I get asked at conferences every so often to explain how Altmetric got started. Here’s that story. Note that this isn’t the story of altmetrics in general, that’s covered in other places. Rather it’s the story of Altmetric the product. I always think of start-ups as involving eureka moments or chance encounters in corridors, but really Altmetric evolved slowly over quite a long period of time. In 2003 I started working in medical genetics at … Read More
Happy New Year! We hope you’ve all had a lovely restful break and are ready for another busy conference season. The end of 2016 was really busy for us with the launch of Explorer for Institutions Version 2 and the release of our Top 100 list. Along with these we also made some exciting new partnerships with PubMed Central and IOP Publishing. We’d love to tell you all our latest news and more about our projects … Read More
Welcome to the final Altmetric High Five for 2016! On a monthly basis, my High Five posts examine a selection of the most popular research outputs Altmetric has seen attention for that month. The most popular research papers published in December 2016 deliver some big news for human health, including positive results of Ebola vaccine trials and health benefits of eating nuts, and some bad news for cheetahs.   Ebola virus. CDC. Paper #1. An Ebola Vaccine Our first High Five paper for December 2016 is “Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease,” published … Read More